Annual report
4465.TEDINET S100YYMP
Period2025-06-01 → 2026-05-31
Filed2026-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 24 passed
Amended by S100Z0B0 (2026-09-04).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.6bn | 2025-06-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥23.7bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥22.7bn | 2023-06-01 → 2024-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.8bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2025-06-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2025-06-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2023-06-01 → 2024-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.7bn | 2025-06-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2025-06-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥706m | 2023-06-01 → 2024-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.2bn | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.9bn | 2025-06-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥23.8bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥22.6bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥22.7bn | at 2024-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥23.6bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.8bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.6bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥16.3bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥14.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.4bn | at 2024-05-31v | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥12.5bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.4bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.8bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.9bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.7bn | at 2023-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.1bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.7bn | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.6bn | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥40m | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥420m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥102m | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥690m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥616m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.4bn | 2025-06-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥946m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2023-06-01 → 2024-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥92m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥789m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥321.01 | 2025-06-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥305.84 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥119.58 | 2023-06-01 → 2024-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥208.59 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,744.08 | at 2026-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,499.68 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,267.35 | at 2024-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,179.33 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,121.49 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 68.2% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.3% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2024-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.3% | 2025-06-01 → 2026-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2023-06-01 → 2024-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 380 | at 2026-05-31 | Cons. | Number of employees |
| Employees | 400 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 394 | at 2024-05-31v | Cons. | Number of employees |
| Employees | 394 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 339 | at 2022-05-31v | Cons. | Number of employees |
| Revenue | ¥21.1bn | 2025-06-01 → 2026-05-31 | Standalone | Net sales |
| Revenue | ¥19.9bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥19.1bn | 2023-06-01 → 2024-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.8bn | 2025-06-01 → 2026-05-31 | Standalone | Operating income |
| Operating income | ¥1.6bn | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Ordinary income | ¥2.0bn | 2025-06-01 → 2026-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.7bn | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2023-06-01 → 2024-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2025-06-01 → 2026-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.0bn | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Net income | ¥1.7bn | 2025-06-01 → 2026-05-31 | Standalone | Profit loss |
| Net income | ¥1.3bn | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥788m | 2023-06-01 → 2024-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥715m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥21.7bn | at 2026-05-31 | Standalone | Assets |
| Total assets | ¥20.5bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥20.7bn | at 2024-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.6bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.6bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.8bn | at 2026-05-31 | Standalone | Liabilities |
| Total liabilities | ¥6.8bn | at 2025-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥14.9bn | at 2026-05-31 | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥12.7bn | at 2024-05-31v | Standalone | Net assets |
| Net assets / equity | ¥12.2bn | at 2023-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥11.7bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2026-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥5.0bn | at 2025-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥291.43 | 2025-06-01 → 2026-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥226.49 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.46 | 2023-06-01 → 2024-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥121.18 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥198.41 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥77 | 2025-06-01 → 2026-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥92 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥44 | 2023-06-01 → 2024-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥64 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,516.81 | at 2026-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,323.58 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,154.42 | at 2024-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,066.02 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,986.14 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 68.8% | at 2026-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.5% | at 2024-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.2% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.0% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.0% | 2025-06-01 → 2026-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.1% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2023-06-01 → 2024-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,943,000 | at 2026-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2024-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,943,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 242 | at 2026-05-31 | Standalone | Number of employees |
| Employees | 242 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 239 | at 2024-05-31v | Standalone | Number of employees |
| Employees | 239 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 231 | at 2022-05-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Chemical Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥525m |
| Chemical Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥496m |
| Chemical Businessreportable segment | employees | at 2026-05-31 | 360 pure |
| Chemical Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥23.3bn |
| Chemical Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥23.3bn |
| Chemical Businessreportable segment | segment assets | at 2026-05-31 | ¥22.0bn |
| Chemical Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥1.9bn |
| Healthcare Businessreportable segment | capex | 2025-06-01 → 2026-05-31 | ¥4m |
| Healthcare Businessreportable segment | depreciation | 2025-06-01 → 2026-05-31 | ¥35m |
| Healthcare Businessreportable segment | employees | at 2026-05-31 | 20 pure |
| Healthcare Businessreportable segment | revenue | 2025-06-01 → 2026-05-31 | ¥1.4bn |
| Healthcare Businessreportable segment | revenue external | 2025-06-01 → 2026-05-31 | ¥1.4bn |
| Healthcare Businessreportable segment | segment assets | at 2026-05-31 | ¥1.9bn |
| Healthcare Businessreportable segment | segment profit | 2025-06-01 → 2026-05-31 | ¥212m |
| —segment total | capex | 2025-06-01 → 2026-05-31 | ¥529m |
| —segment total | depreciation | 2025-06-01 → 2026-05-31 | ¥531m |
| —segment total | revenue | 2025-06-01 → 2026-05-31 | ¥24.6bn |
| —segment total | revenue external | 2025-06-01 → 2026-05-31 | ¥24.6bn |
| —segment total | segment assets | at 2026-05-31 | ¥23.8bn |
| —segment total | segment profit | 2025-06-01 → 2026-05-31 | ¥2.1bn |
| Chemical Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥442m |
| Chemical Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥497m |
| Chemical Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥22.2bn |
| Chemical Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥22.2bn |
| Chemical Businessreportable segment | segment assets | at 2025-05-31 | ¥20.7bn |
| Chemical Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥1.6bn |
| Healthcare Businessreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥9m |
| Healthcare Businessreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥36m |
| Healthcare Businessreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.5bn |
| Healthcare Businessreportable segment | segment assets | at 2025-05-31 | ¥1.8bn |
| Healthcare Businessreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥278m |
| —segment total | capex | 2024-06-01 → 2025-05-31 | ¥451m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥533m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥23.7bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥23.7bn |
| —segment total | segment assets | at 2025-05-31 | ¥22.6bn |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥1.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,587
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 93 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 89 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 91 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 99 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 111 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.837 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.802 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.766 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.887 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.954 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.018 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.166 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.552 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.608 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 2.324 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 20 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 12 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 2 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 2.7 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 6 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 7 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 100 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row4Member | 89 | |
| Research and development expenses research and development activities | CurrentYearDuration | 304000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00890-000ChemicalBusinessReportableSegmentsMember | 291000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00890-000HealthcareBusinessReportableSegmentsMember | 12000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 529000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00890-000ChemicalBusinessReportableSegmentsMember | 525000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00890-000HealthcareBusinessReportableSegmentsMember | 3000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5943052 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5943052 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 5943052 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 5943052 | |
| Number of shares constituting one unit | RecordDateInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | RecordDateInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | RecordDateInstant_OrdinaryShareMember | 8 | |
| Number of shareholders financial service providers | RecordDateInstant_OrdinaryShareMember | 18 | |
| Number of shareholders other corporations | RecordDateInstant_OrdinaryShareMember | 86 | |
| Number of shareholders foreign investors other than individuals | RecordDateInstant_OrdinaryShareMember | 44 | |
| Number of shareholders foreign individual investors | RecordDateInstant_OrdinaryShareMember | 9 | |
| Number of shareholders individuals and others | RecordDateInstant_OrdinaryShareMember | 6636 | |
| Number of shareholders total | RecordDateInstant_OrdinaryShareMember | 6801 | |
| Number of shares held number of units national and local governments | RecordDateInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | RecordDateInstant_OrdinaryShareMember | 3413 | |
| Number of shares held number of units financial service providers | RecordDateInstant_OrdinaryShareMember | 1548 | |
| Number of shares held number of units other corporations | RecordDateInstant_OrdinaryShareMember | 19859 | |
| Number of shares held number of units foreign investors other than individuals | RecordDateInstant_OrdinaryShareMember | 4182 | |
| Number of shares held number of units foreign individual investors | RecordDateInstant_OrdinaryShareMember | 13 | |
| Number of shares held number of units individuals and others | RecordDateInstant_OrdinaryShareMember | 30275 | |
| Number of shares held number of units total | RecordDateInstant_OrdinaryShareMember | 59290 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | partial |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |